Clinical Trials in Colorado

Showing 12921-12940 of 18,143 trials

DNS-7801 vs. Placebo in Parkinson's Disease

NCT03306329

This is a randomized, double-blind, two-part placebo-controlled parallel group outpatient treatment study that will utilize standard Parkinson's Disease measures to evaluate the effect of DNS-7801

Parkinson's Disease

Dart NeuroScience, LLC5 participantsStarted Sep 2017

Long Beach, California, United States • Pasadena, California, United States • Englewood, Colorado, United States +6 more locations

COMPLETEDPhase 244 miles

Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci

NCT00428844

This is a research study designed to look at the efficacy and safety of daptomycin given at a dose of 6 mg/kg or 8 mg/kg in subjects being treated for prosthetic hip or knee infections caused by Staphylococci. These types of bacteria are among the most common types of bacteria causing infections of prosthetic joints.

Osteomyelitis

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)75 participantsStarted Jun 2007

Little Rock, Arkansas, United States • Englewood, Colorado, United States • Washington D.C., District of Columbia, United States +23 more locations

DNS-7801 vs. Placebo in Parkinson's Disease

Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci

Find Trials by Condition in Colorado

Lesinurad and Febuxostat Combination Extension Study in Gout

Auricular Acupuncture For The Treatment Of Non-Epileptic Seizures

Study of Bendamustine Hydrochloride and Rituximab (BR) Compared With R-CVP or R-CHOP in the First-Line Treatment of Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL) - Referred to as the BRIGHT Study

The Effects of A Proprietary Spearmint Extract on Cognitive Performance

Validation of BD Onclarity™ HPV Assay With PreservCyt® -ASCUS Samples

A Study of Intravenous XMT-1001 in Patients With Advanced Solid Tumors

A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis

Energy Expenditure and Weight Loss Maintenance

A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab Compared to Bevacizumab Alone or Onartuzumab Monotherapy in Participants With Recurrent Glioblastoma

Trans Health: Evaluation of Markers of Cardio-metabolic Health and Well-being in Transgender Youth

A Study of DCC-2701 in Participants With Advanced Solid Tumors

Safety and Effectiveness Study of the AcuFocus Corneal Inlay ACI 7000PDT in Presbyopes

Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery

Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer

Open Label Phase Two Trial of Radium Ra 223 Dichloride With Concurrent Administration of Abiraterone Acetate Plus Prednisone in Symptomatic Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Bone Metastasis

A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers

Diagnosis and Treatment of ACS in the ED: The Impact of Rapid Bedside cTnI Testing on Outcomes

IV Iron for the Anemia of Traumatic Critical Illness